The PCoA analysis of microbiome data with weighted UniFrac distance showed 153 clustering between both lungs of patient 1 and the right lung of patient 3 along the first two 154 principal axes ( Supplementary Figure 2a) . Samples from the left lung of patient 3 clustered 
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To map the relative frequency of microbes onto the 3D lung models, we used our 173 previously described methodology (16) . The distribution of prevalent (Pseudomonas and 174 Staphylococcus) and emerging (Stenotrophomonas and Achromobacter) microbes in the CF-175 associated lungs is displayed in Figure 2 . Although nearly uniform distribution of dominant 176 pathogens (Pseudomonas in patients 1 and 3, Stenotrophomonas in patient 2) was observed, 177 all other microbes were distributed unevenly, often relegated to niche spots. For example,
178
Achromobacter was mainly localized in the apex of the right lung of patient 3 while 179 Staphylococcus was present in the lower lobe of both lungs of patient 1, at the apex of the lungs 180 of patient 2 and in the middle and lower lobes of the lungs of patient 3. The dominant pathogen,
181
Stenotrophomonas, showed uniform distribution in the lungs of the patient 2 and differential 182 distributions in the lungs of patients 1 and 3 ( Figure 2) . A degree of stratification is expected 183 based on the availability of oxygen: Achromobacter and Stenotrophomonas are strict aerobes 184 whereas Staphylococcus and Pseudomonas are facultative anaerobes residing as biofilms in 185 airway mucus of CF patients with the potential of undergoing anaerobic metabolism (29).
186
Furthermore, patients 1 and 3 not only share the dominant pathogen, their microbial 187 communities are also more similar to each other than either is to that of the patient 2 188 ( Supplementary Figure 3 
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To annotate molecular ions detected using high resolution mass spectrometry (MS)-200 based untargeted approach, molecular network analysis was performed using the Global 201 Natural Product Social Molecular Networking (GNPS) infrastructure (30). Molecular networking 202 allows for reduction and organization of the overwhelming amount of chemical information 203 generated (in terms of mass spectra) in a high-resolution untargeted MS approach. The data 204 reduction is performed by combining and displaying the identical MS/MS spectra as a single 205 node and by displaying similar spectra as connected nodes (30, 31) . Similarities in MS/MS 206 spectra relate to similarities in chemical structures, so oftentimes such connected nodes 207 represent chemical and biological transformations of a molecule. In this study, 676,451 MS/MS 208 spectra were filtered and merged into consensus spectra, producing 9,874 nodes ( Figure 3a ).
209
The patient-specific molecules were displayed by assigning a specific color to each patient in 210 the molecular network analysis (Figure 3a ). In addition to annotating known compounds, 211 molecular networking revealed related molecules that differ by oxidation, methylation, 212 acetylation, hydroxylation, glycosylation, chain length, and saturation of alkyl chains, which 213 enabled identification of previously undescribed metabolites of administered pharmaceuticals 214 and microbial quinolones, as described below for azithromycin and Pseudomonas aeruginosa 215 quinolones. The frequency of detection of the antibiotics across patients' samples is shown in 216 Figure 3b , with corresponding clusters from the full network displayed for each antibiotic. The 217 nodes in antibiotic cluster represent the metabolic transformations of the antibiotic. Thus, 218 molecular networking provides a glimpse into metabolic processes. The resulting molecular 219 network revealed that among three patients, remarkably, only about 27.6% of detected 220 molecular features were shared, highlighting the diversity of chemistry present in diseased 221 human lungs ( Figure 3c ). All three patients in this study had different mutations in the CFTR 222 gene (see Materials and Methods) and patients 2 and 3 were also diagnosed with CF-related which may arise from microbial (e.g., virulence and quorum sensing metabolites such as 226 quinolones), host (e.g., bile acids, amino acids, sugars, eukaryotic lipids, fatty acids, sterols, 227 peptides, immune-related molecules), and xenobiotic molecules. The diversity of these 228 metabolites in CF sputum has been previously characterized and many of the same compounds 229 were also found in the lung tissue in this study (32). 12 231 232 
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a) The molecular network is color coded by patients (patient 1 (blue), patient 2 (green), and 234 patient 3 (orange). The network clusters corresponding to antibiotics are highlighted in boxes.
235
b) The number of samples that contain a given consensus MS/MS spectra (represented as node in Figure 3a ) are plotted. The frequency of occurrence of antibiotics detected in this 237 dataset is highlighted on the plot. The number of nodes in a cluster is reflective of detected 238 transformations of the parent compound. The node of parent compound is highlighted by 239 asterisks. The fragmentation patterns of the most frequently observed drug -azithromycin and 240 its analogs are described in Supplementary Figure 7 ; the large number of nodes in Piperacillin 241 cluster stems from its structural similarity to small peptidic compounds abundant in biological 242 samples and its inherent chemical reactivity with biological molecules (33). c) Venn diagram of 243 the overlap of consensus fragmentation spectra between three patients is shown.
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A Procrustes analysis of metabolomics data and 16S rRNA data with closed-reference 246 OTU picking revealed a close association between the microbiome and metabolome in the lung the metabolome data with Canberra distance showed that a vast chemical diversity exists not 253 only between the patients (Figure 1c ), but also within a patient's own lungs (Supplementary 254 table 2). This suggests that the chemical makeup of the patients with CF disease is highly 255 personalized and that a single CF lung contains unique chemical microenvironments that 256 provide different niches for microbial pathogens to live in. While metabolic diversity between 257 patients in relation to disease state is previously described (32, 35) , mechanisms leading to 258 such diversity within the lungs remain poorly understood.
259
One of the additional benefits of an untargeted metabolomics analysis approach is the 260 ability to track the medications that are taken by the patient, as medical records can oftentimes 261 be incomplete and/or inaccurate due to lack of patient compliance, as well as to identify 262 metabolic transformations of the medications. For example, in the present study, in addition to 263 the prescribed medications from the clinical records (different antibiotics, bronchodilators, two 264 medications for digestive health, medications given during surgery and over-the-counter 265 medications that are used as cough suppressants), antihistamines and multiple over the counter 266 medications have been detected (Table 1) with Pseudomonas, we investigated the distribution of quinolones directly within the lungs of 328 these patients (Figure 5b and Supplementary Figure 11 ). Previously, we reported that the 329 quinolones were prevalent at the upper lobe of the left lung of a single patient (16). In this study 330 quinolones were found to be exclusively present at the upper lobe of lungs of patient 1 and only 331 in the middle of the lungs of patient 3. This indicates that patients dominated by Pseudomonas 332 show individualized phenotypes with respect to the expression of these quorum sensing 333 molecules. Furthermore, rhamnolipids, the Pseudomonas' biosurfactant, were not detected in 334 the lungs of patient 1 and 3 in this study but were detected in our previous study (16) . Patient-335 specific production of rhamnolipids has been reported previously by culturing isolates in the 336 laboratory but not directly from infected tissue (13). Such compartmentalization of microbial activity within patients, as well as variation between patients is a hallmark of complexity that is 338 inherent to polymicrobial infection in a complex organ; in the present case, a CF lung. Direct 339 visualization of the individual phenotypes in diseased organs enables informed understanding of 340 divergent evolution as well as the spatial molecular environment within a host. Figure 12) .
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The spatial co-distribution of microorganisms, antibiotics and microbial molecules were Figures 12b) . This, and the other observations reported here 372 support the hypothesis that not only are genetic changes responsible for changing metabolism, 373 but microbial interactions in conjunction with multiple other factors including sub-MIC 374 concentrations of antibiotics and perhaps other xenobiotics may also play a role and call for the 375 design of specific studies investigating these phenomena in multiple patient isolates. Thus, it is 376 reasonable to hypothesize that both specific microbial interactions in the lungs and differential 377 abundances of antibiotics could result in metabolic divergence, creating isolated regions of enhanced biofilm formation and tissue damage that is often observed in CF patients by chest X-379 rays and CT-scans. Application of advanced techniques such as Ultra-High-Resolution
380
Computed Tomography in conjunction with the approach presented here could be a focus of 381 future studies (38).
383

Conclusion
384
Cystic fibrosis is a devastating genetic disease which affects tens of thousands of people 385 worldwide. In this work, we presented the findings of spatial distributions of microbes, 386 medications, and their metabolites throughout lungs of three patients afflicted with CF. We have 387 found that although the microbiome is predominantly patient-specific, the chemical differences 388 between locations within patient's own lungs may be greater than inter-patient variations. In-389 depth analyses revealed differential drug penetration, metabolism of prescribed medications, 
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Supplementary 
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Tissue collection and processing. To map the microbiome and metabolome of explanted 482 lungs in 3D, the lungs of three patients were obtained in close coordination with the patient's 483 physician and the surgical team. This work was approved by the University of California
484
Institutional Review Board (project #081500) and informed consents were obtained prior to 485 tissue collection. The CFTR mutation in Patient 1 was dF508/G551D with no clinical diabetes, in 486 patient 2 was dF508/3120+1G>A with observed clinical diabetes and in patient 3 was 487 dF508/dF508 with observed clinical diabetes. The general workflow for tissue sectioning is 488 described previously (16). Briefly, both the right and left lungs for subject 1, 2, and 3 were 
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Statistical analysis was carried out as follows: QIIME 1.9.1 was used to perform principal-555 coordinate analysis (PCoA) (beta_diversity.py, a Canberra distance metric in Adkins form). The
556
PCoA plots were visualized in EMPeror (28).
558
Molecular networking. The molecular network was created using the online workflow at GNPS 559 platform. The data was then clustered with MS-Cluster with a parent mass tolerance of 0.1 Da 560 and a MS/MS fragment ion tolerance of 0.1 Da to create consensus spectra. Further, consensus 561 spectra that contained less than 3 spectra were discarded. A network was then created where 562 edges were filtered to have a cosine score above 0.7 and more than 4 matched peaks. The 563 edges between two nodes were kept in the network if and only if each of the nodes appeared in 564 each other's respective top 10 most similar nodes. The spectra in the network were then 565 searched against GNPS's spectral libraries. All matches kept between network spectra and 566 library spectra were required to have a score above 0.7 and at least 4 matched peaks. The 567 molecular networks and the parameters used are available at the links below:
568
The molecular network and parameters for the patient data are available at: 
573
In total, 1776 of the nodes were annotated (7.8%) which is higher than the typical rate of 574 annotations of 1.8% annotated in an untargeted metabolomics experiment (30). This is likely 575 because many of the reference MS/MS libraries in the public domain are populated from studies 576 of human samples and also contain most of therapeutics used in the clinic. The error rate of 577 these annotations have been assessed by the GNPS community; with the scoring settings used 578 to obtain the annotations, 1% of which are deemed incorrect, for 4% not enough information is 579 available and 4% could be an isomer or correct, while 91% is presumed correct (30).
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16S rRNA gene analysis. As described above, sequences were obtained over the course of 582 two months through two independent sequencing runs. The samples for patient 1 and patient 2 583 were sequenced in one batch and samples for patient 3 were sequenced separately. Each set 584 of sequences were processed and analyzed using Qiita (43). First, the sequencing runs were 585 quality trimmed and filtered using default parameters, resulting in 15,629,914 sequences with a 586 mean length of 150 nucleotides. Next, trimmed sequences (at 150 nucleotides) were clustered 587 into operational taxonomic units (OTUs) using the closed reference OTU picking method at 97% 588 sequence similarity. UCLUST was the underlying clustering algorithm and Greengenes (August analysis. And the last 7 samples were represented by over 6,000 sequences each. Although the 601 last sample set was processed without any DNA, the well-to-well contamination during the DNA 602 extraction step yielded these sequences. We removed these samples since the DNA is 603 biological and not representative of a type of actionable contamination (45, 46) .
605
For statistical analysis, QIIME2 (47) was used to perform PCoA (Canberra (in Adkins form),
606
weighted, and unweighted UniFrac distances (weighted UniFrac distances (48)) and Procrustes 607 analysis with metabolomics data. The PCoA and Procrustes plots were visualized in EMPeror 608 (28) . The Mantel test was used to calculate r 2 scores between mass spectrometry and for both
